These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 23571482)
1. Increased expression of connective tissue growth factor and transforming growth factor-beta-1 in atrial myocardium of patients with chronic atrial fibrillation. Li Y; Jian Z; Yang ZY; Chen L; Wang XF; Ma RY; Xiao YB Cardiology; 2013; 124(4):233-40. PubMed ID: 23571482 [TBL] [Abstract][Full Text] [Related]
2. Increased α-Actinin-2 Expression in the Atrial Myocardium of Patients with Atrial Fibrillation Related to Rheumatic Heart Disease. Zhang L; Zhang N; Tang X; Liu F; Luo S; Xiao H Cardiology; 2016; 135(3):151-159. PubMed ID: 27344599 [TBL] [Abstract][Full Text] [Related]
3. Role of the MAPKs/TGF-β1/TRAF6 signaling pathway in atrial fibrosis of patients with chronic atrial fibrillation and rheumatic mitral valve disease. Zhang D; Liu X; Chen X; Gu J; Li F; Zhang W; Zheng Y Cardiology; 2014; 129(4):216-23. PubMed ID: 25376239 [TBL] [Abstract][Full Text] [Related]
4. Calreticulin overexpression correlates with integrin-α5 and transforming growth factor-β1 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation. Zhao F; Zhang S; Shao Y; Wu Y; Qin J; Chen Y; Chen L; Gu H; Wang X; Huang C; Zhang W Int J Cardiol; 2013 Oct; 168(3):2177-85. PubMed ID: 23465222 [TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid ameliorates early cardiac dysfunction after coronary microembolization and suppresses TGF-β1/Smad3 and CTGF expression. Chen Z; Qian J; Ma J; Chang S; Yun H; Jin H; Sun A; Zou Y; Ge J Int J Cardiol; 2013 Sep; 167(5):2278-84. PubMed ID: 22727959 [TBL] [Abstract][Full Text] [Related]
6. TGFβ1 and HGF regulate CTGF expression in human atrial fibroblasts and are involved in atrial remodelling in patients with rheumatic heart disease. Chen JQ; Guo YS; Chen Q; Cheng XL; Xiang GJ; Chen MY; Wu HL; Huang QL; Zhu PL; Zhang JC J Cell Mol Med; 2019 Apr; 23(4):3032-3039. PubMed ID: 30697920 [TBL] [Abstract][Full Text] [Related]
7. [Effect of hepatocyte growth factor and transforming growth factor-β(1) on atrial fibroblasts fibrosis]. Zhang JC; Chen JQ; Xu CX; Chen L; Lin YZ; Wu GS Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Oct; 40(10):834-9. PubMed ID: 23302670 [TBL] [Abstract][Full Text] [Related]
8. [Expression of transforming growth factor-beta1 and connective tissue growing factor in schistosomal hepatic fibrosis of mice]. Huang JQ; Zhu J; Li L; Jiao YT; Xu L; Tao R; Fan XX; Ma K; Guo W; Ning Q Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2012 Feb; 30(1):20-6. PubMed ID: 22913183 [TBL] [Abstract][Full Text] [Related]
10. Atrial fibrosis and atrial fibrillation: the role of the TGF-β1 signaling pathway. Gramley F; Lorenzen J; Koellensperger E; Kettering K; Weiss C; Munzel T Int J Cardiol; 2010 Sep; 143(3):405-13. PubMed ID: 19394095 [TBL] [Abstract][Full Text] [Related]
11. Increased TRPM6 expression in atrial fibrillation patients contribute to atrial fibrosis. Zhang YJ; Ma N; Su F; Liu H; Mei J Exp Mol Pathol; 2015 Jun; 98(3):486-90. PubMed ID: 25796343 [TBL] [Abstract][Full Text] [Related]
12. Role of the MAPKs/TGF-β1/TRAF6 signaling pathway in postoperative atrial fibrillation. Zhang D; Chen X; Wang Q; Wu S; Zheng Y; Liu X PLoS One; 2017; 12(3):e0173759. PubMed ID: 28323847 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts. Gu J; Liu X; Wang QX; Tan HW; Guo M; Jiang WF; Zhou L Exp Cell Res; 2012 Oct; 318(16):2105-15. PubMed ID: 22749815 [TBL] [Abstract][Full Text] [Related]
14. Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation. Adam O; Lavall D; Theobald K; Hohl M; Grube M; Ameling S; Sussman MA; Rosenkranz S; Kroemer HK; Schäfers HJ; Böhm M; Laufs U J Am Coll Cardiol; 2010 Feb; 55(5):469-80. PubMed ID: 20117462 [TBL] [Abstract][Full Text] [Related]
15. TGF-beta1 expression and atrial myocardium fibrosis increase in atrial fibrillation secondary to rheumatic heart disease. Xiao H; Lei H; Qin S; Ma K; Wang X Clin Cardiol; 2010 Mar; 33(3):149-56. PubMed ID: 20235205 [TBL] [Abstract][Full Text] [Related]
16. Galectin-3 Induces Atrial Fibrosis by Activating the TGF-β1/Smad Pathway in Patients with Atrial Fibrillation. Xiao M; Zhang M; Bie M; Wang X; Guo J; Xiao H Cardiology; 2020; 145(7):446-455. PubMed ID: 32516780 [TBL] [Abstract][Full Text] [Related]
17. Increased expression of NF-AT3 and NF-AT4 in the atria correlates with procollagen I carboxyl terminal peptide and TGF-β1 levels in serum of patients with atrial fibrillation. Zhao F; Zhang S; Chen Y; Gu W; Ni B; Shao Y; Wu Y; Qin J BMC Cardiovasc Disord; 2014 Nov; 14():167. PubMed ID: 25422138 [TBL] [Abstract][Full Text] [Related]
18. [Expression of mineralocorticoid receptor and 11-beta-hydroxysteroid dehydrogenase type 2 in human atria during chronic atrial fibrillation: study of 25 cases]. Pei DA; Li L; Xu ZY; Zou LJ; Zhang BR; Huang SD; Hao JH; Wang ZN; Lu FL Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):816-9. PubMed ID: 17565863 [TBL] [Abstract][Full Text] [Related]
20. Plasma transforming growth factor beta1 as a biochemical marker to predict the persistence of atrial fibrillation after the surgical maze procedure. On YK; Jeon ES; Lee SY; Shin DH; Choi JO; Sung J; Kim JS; Sung K; Park P J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1515-20. PubMed ID: 19464473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]